title: The place of PD-1 inhibitors in melanoma management.
authors.affiliation: Rockingham General Hospital, Cooloongup, WA, Australia.
authors.forename: Samantha
authors.initials: S
authors.lastname: Bowyer
authors.affiliation: Christie NHS Foundation Trust and University of Manchester, Manchester, M20 4BX, UK. Electronic address: paul.lorigan@christie.nhs.uk.
authors.forename: Paul
authors.initials: P
authors.lastname: Lorigan
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents